Among individuals with relapsing-remitting MS, intermittent calorie restriction and ketogenic diets reduce metabolomic age.

Jeanette Tinggaard, Ph.D., from Copenhagen University Hospital in Denmark, and colleagues estimated the cumulative risk for epilepsy after neonatal seizures and identified subpopulations at increased ...

The U.S. Employee Perspectives on Managing Chronic Conditions in the Workplace poll was conducted Oct. 2 to 16, 2024, and included a nationally representative sample of the 1,010 part-time and ...

Serious neurologic complications are uncommon among young children with influenza but occur more often among those with underlying neurologic conditions.

Smoking and high-intensity smoking are associated with cryptogenic ischemic stroke (CIS) among adults aged 18 to 45 years.

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

Children with pediatric-onset multiple sclerosis (POMS) have shorter telomeres, suggesting MS may accelerate biological aging.

For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.

Ozanimod treatment for early relapsing multiple sclerosis helps prevent impaired cognitive functioning during the first year of use.

Cladribine treatment for relapsing multiple sclerosis improves health-related quality of life and preserves cognitive function after 4 years.

Mild cognitive impairment and Alzheimer disease have a low prevalence among newly diagnosed patients with multiple sclerosis.

Efficacy of treatment is maintained during the switch from IV anti-CD20 therapies to ofatumumab in relapsing MS regardless of race/ethnicity.